Inhaled short-acting beta agonist treatment-associated supraventricular tachycardia in children: still a matter of concern in pediatric emergency departments?

HIGHLIGHTS

• who: Bertrand Tchana and Carlo Caffarelli from the Pediatric Cardiology Division, Parma General and University Hospital, Parma, Italy have published the Article: Inhaled Short-Acting Beta Agonist Treatment-Associated Supraventricular Tachycardia in Children: Still a Matter of Concern in Pediatric Emergency Departments?, in the Journal: Children 2023, 699 of 31/Dec/2022
• what: Cardiovascular events including supraventricular arrhythmias are the most frequent side effects reported with inhaled SABA in children with asthma and are the main reason for a continuing debate about their safety despite their widespread use. In children, acute exacerbations of asthma are . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.